Phase II Trial of Escalated Dose Proton Radiotherapy With Elective Nodal Irradiation and Concomitant Chemotherapy for Patients With Unresectable, Borderline Resectable or Medically Inoperable Pancreatic Adenocarcinoma
The purpose of this phase II trial is to evaluate the safety and efficacy of proton radiation therapy in combination with Capecitabine in patients with localized pancreatic adenocarcinoma.
Study ID: PAN009-18
Trial Phase: Phase II
Trial Sponsor: Proton Collaborative Group
Therapies Used in This Trial: Capecitabine, Proton Radiation, Surgery